决定异体 CAR T 细胞排斥与扩增的细胞和分子机制
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.
我们评估了11例接受单一批次cemacabtagene ansegedleucel(cema-cel)治疗的大B细胞淋巴瘤患者,cemacabtagene ansegedleucel是一种异体抗CD19 CAR T产品。
英文原题:Infectious mononucleosis complicated by transitory Epstein-Barr virus infection of T and natural killer cells.
这些发现表明,IM 中的 EBV + T/NK 细胞可作为有价值的诊断依据。
EB病毒通常在传染性单核细胞增多症中感染B细胞,但少数病例可感染T细胞。本研究报告7例淋巴结中EBV阳性细胞毒性T/NK细胞增殖所致淋巴增殖性疾病,即伴T/NK细胞短暂感染的传染性单核细胞增多症,并回顾其临床病理特征。患者为中国儿童及青年,发病突然,均以高热起病,随后出现淋巴结肿大和肝脾肿大,多在症状出现1.5个月内确诊。病灶淋巴细胞多表达CD3和颗粒酶B或TIA-1;部分病例大量细胞表达CD56。EBER在中至大型细胞中阳性,6例检出TCR基因重排,其中4例为单克隆。患者接受保守、抗HLH或抗炎治疗,长期随访均存活。EBV阳性T/NK细胞可呈现类似淋巴瘤的恶性病理特征,却具有类似单核细胞增多症的良性临床表现。准确诊断和预后评估需结合年龄、急性起病、病程短、全身症状、急性感染及淋巴结受累等临床信息。
Epstein-Barr virus (EBV) typically infects B cells in infectious mononucleosis (IM), but a rare case shows EBV infection in T cells. Seven cases of lymphoproliferative disorder caused by EBV-positive cytotoxic T/natural killer (NK) cell proliferation in the lymph nodes, termed IM with transient EBV infection of T and NK cells (EBV + T/NK cells in IM), are reported here. The purpose of the study is to describe clinicopathological features of EBV + T/natural killer (NK) cells in IM of the lymph node. We retrospectively analysed seven cases of Chinese children and young people adults with EBV + T/NK cells in IM. We used morphological observation, immunohistochemical staining, EB virus in situ hybridisation detection, and analysis of T-cell receptor gene rearrangement. The patients were healthy prior to illness, experiencing sudden onset occurring in all the patients, with high fever as the first symptom, followed by lymphadenopathy and hepatosplenomegaly. Diagnosis occurred < 1.5 months of symptom onset. Most lymphocytes in lesions expressed CD3 and Granzyme B or TIA-1 and lacked CD5. CD56 was expressed in numerous cells in 5 of the 7 cases. EBV-encoded RNA (EBER) was detected in medium-to-large-sized cells (50-100 cells per cell/high-power field). T-cell receptor (TCR) gene rearrangement was seen in six cases, with monoclonal rearrangement in four cases. Treatment was conservative treatment but not chemotherapy. Four received anti-HLH therapy and others anti-inflammatory treatment. All patients survived with relapse after long-term clinical observation and follow-up. EBV + T/NK cells in IM can elicit malignant features that mimic T/NK-cell lymphoma pathologically and benign features mimicking IM clinically. These findings indicate that EBV + T/NK cells in IM could serve as valuable diagnosis. Additional clinical information, including age of onset (children and young people), nature of onset (sudden), disease course (short), symptoms (systemic), EBV infection status (acute), and lymph node involvement, is crucial for accurate diagnosis and prognostic evaluation.
MEMBER ACCOUNT
登录成功会直接打开下一页。